China has found another vulnerability in America’s borders and supply chain - and it's being exploited.An illicit pipeline is bringing an experimental injectable drug from Chinese chemical manufacturers directly into American homes.The drug is retatrutide, commonly called "reta," and is in clinical trials as a potential treatment for obesity and type 2 diabetes.
This means there is no FDA-approved version, no lawful generic and it’s illegal to sell to patients.But the national security concern goes far beyond one drug.JILLIAN MICHAELS EXPOSES DANGERS OF SELF-DOSING ILLEGAL 'GRAY MARKET' WEIGHT LOSS DRUGSWhat we are witnessing is an illegal international supply chain that begins with chemical suppliers in Communist China, moves through customs fraud and concealed shipments, is relabeled by American middlemen and ends with an unapproved injectable drug in an American home.We’ve seen this playbook before.CLOSE THE BACKDOOR DRUG PIPELINE THAT’S EMBOLDENING ENEMIES AND HARMING THE PUBLICFor years, Chinese chemical companies have supplied precursor chemicals used by cartels to make fentanyl.Now there is evidence that elements of this same infrastructure are being used for another lucrative American market: people looking for weight-loss drugs.Blockchain researchers at Chainalysis were able to track proceeds from U.S.
peptide sales flowing back to China-based chemical manufacturers that have produced synthetic opioids, such as fentanyl.TRM Labs has similarly detected a pattern of Chinese chemical companies that produce fentanyl precursors turning to the "peptide business."EXPERT WARNS CHINA ALREADY WAGING ‘UNRESTRICTED WARFARE’ AGAINST US THROUGH FENTANYL, ESPIONAGE AND SABOTAGEThis should set off alarm bells across Washington.The fentanyl crisis demonstrated what happens when foreign chemical suppliers, transnational criminal organizations and illicit financial networks exploit weaknesses in America’s borders and supply chains.
We cannot make the same mis...